# Cue Biopharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:3731638e-186d-4843-b67f-ed30d12dca58 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/cue-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:47.349247+00:00 | | Last reviewed | 2026-10-17T04:46:47.349247+00:00 | ## Identity - Legal name: Cue Biopharma, Inc. - Display name: Cue Biopharma, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T09:03:42.715304+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 7 | | Committees | 5 | | Governance events | 18 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Frank Morich: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:5 - Jill Broadfoot: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:6 - Pamela D. Garzone: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:7 - Pasha Sarraf: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:8 - Patrick Verheyen: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:9 - Peter A. Kiener: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:10 - Usman Azam: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:11 ## Committees - Audit (audit). Chair: Jill Broadfoot. Members: Jill Broadfoot (chair, current); Patrick Verheyen (member, current). committee_id=alpha:committee:cue-biopharma-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Jill Broadfoot (member, current). committee_id=alpha:committee:cue-biopharma-inc:audit-chair - Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Patrick Verheyen (member, current). committee_id=alpha:committee:cue-biopharma-inc:audit-compensation - Compensation (compensation). Chair: Peter A. Kiener. Members: Peter A. Kiener (chair, current); Pamela D. Garzone (member, current); Patrick Verheyen (member, current). committee_id=alpha:committee:cue-biopharma-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Peter A. Kiener (member, current). committee_id=alpha:committee:cue-biopharma-inc:compensation-chair ## Executive leadership - Colin G. Sandercock: Senior Vice President, General Counsel and Secretary [GC]. Status: current. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:12 - Douglas G. Baker: Interim Chief Development Officer. Status: current. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:13 - Lucinda Warren: Chief Financial and Business Officer. Status: current. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:14 - Usman Azam: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:15 ## Governance events - GC_CHANGED: Colin G. Sandercock executive of Cue Biopharma, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:18c923xy9tlt3 - EXECUTIVE_APPOINTED: Douglas G. Baker executive of Cue Biopharma, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:x9ihqj10byz8p - EXECUTIVE_APPOINTED: Lucinda Warren executive of Cue Biopharma, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:ykhy614lnd4g - CEO_CHANGED: Usman Azam executive of Cue Biopharma, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:w3el04f84io - DIRECTOR_APPOINTED: Jill Broadfoot seat on Cue Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:pn5shof79oi8 - DIRECTOR_APPOINTED: Pasha Sarraf seat on Cue Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:11hv6qqunruza - DIRECTOR_APPOINTED: Usman Azam seat on Cue Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:hra8b618py3k6 - COMMITTEE_CREATED: Audit · Chair committee of Cue Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:qle6q1orcwsk - COMMITTEE_MEMBER_ADDED: Jill Broadfoot member of Audit · Chair, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:l3awi2prn5cs - DIRECTOR_APPOINTED: Pamela D. Garzone seat on Cue Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:u8ywbt1an48yr - DIRECTOR_APPOINTED: Patrick Verheyen seat on Cue Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:i7gqo3hwh3sl - COMMITTEE_CREATED: Audit; Compensation committee of Cue Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1bgn9in1dhxpyd - COMMITTEE_MEMBER_ADDED: Patrick Verheyen member of Audit; Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:16d6pp28rqizk - COMMITTEE_MEMBER_ADDED: Pamela D. Garzone member of Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:123n1i7256nw9 - DIRECTOR_APPOINTED: Frank Morich seat on Cue Biopharma, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1apnwultz3rwd - DIRECTOR_APPOINTED: Peter A. Kiener seat on Cue Biopharma, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1ti7ba77ylpjr - COMMITTEE_CREATED: Compensation · Chair committee of Cue Biopharma, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1818w2f2zbtrj - COMMITTEE_MEMBER_ADDED: Peter A. Kiener member of Compensation · Chair, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:zhsh261csspj2 ## Scoped resources - `alpha://company/cue-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record - `alpha://company/cue-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=identity - `alpha://company/cue-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/cue-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=board - `alpha://company/cue-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=committees - `alpha://company/cue-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=leadership - `alpha://company/cue-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=ownership - `alpha://company/cue-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=financials - `alpha://company/cue-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=capital-structure - `alpha://company/cue-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=compensation - `alpha://company/cue-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=governance - `alpha://company/cue-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/cue-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=audit - `alpha://company/cue-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=legal - `alpha://company/cue-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=risk - `alpha://company/cue-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=cyber - `alpha://company/cue-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=ai-governance - `alpha://company/cue-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=agents - `alpha://company/cue-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=ecosystem - `alpha://company/cue-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=events - `alpha://company/cue-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=relationships - `alpha://company/cue-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=assessments - `alpha://company/cue-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:jill-broadfoot","name":"Jill Broadfoot"},"source_id":"board_seats"}` - Claim alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:patrick-verheyen","name":"Patrick Verheyen"},"source_id":"board_seats"}` - Claim alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:peter-a-kiener","name":"Peter A. Kiener"},"source_id":"board_seats"}` - Claim alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:pamela-d-garzone","name":"Pamela D. Garzone"},"source_id":"board_seats"}` - Claim alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:patrick-verheyen","name":"Patrick Verheyen"},"source_id":"board_seats"}` ## Leadership - Frank Morich: Director. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:5. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Jill Broadfoot: Director, Audit · Chair. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Pamela D. Garzone: Director, Compensation. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Pasha Sarraf: Director. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Patrick Verheyen: Director, Audit; Compensation. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Peter A. Kiener: Director, Compensation · Chair. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:10. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Usman Azam: Director. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:11. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3. - Colin G. Sandercock: Senior Vice President, General Counsel and Secretary. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:12. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2bdf35e890076f9f2a3f2f6f84355052fb69c6f42337463f00d1ad0dbd2de18. - Douglas G. Baker: Interim Chief Development Officer. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:13. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eaf99dd1aa5589b67b845e81ab128e8659000f4a69491c7b0b9e3102a9c9232e. - Lucinda Warren: Chief Financial and Business Officer. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:14. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b6e883872219ad0914e20ee2f9be70862e3d2d522fddd466b231674b9e54182e. - Usman Azam: President, Chief Executive Officer and Director. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:leadership_role:15. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7d3f1d080fef62e8530fa46ff892f1aa18bd2ac7212e7d068210b46cb5c50710. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Jill Broadfoot; Members Jill Broadfoot (Chair); Patrick Verheyen. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. - Compensation: Chair Peter A. Kiener; Members Peter A. Kiener (Chair); Pamela D. Garzone; Patrick Verheyen. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Cue Biopharma, Inc.. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd2c8d8b5bf3aaa51a8430f5d636b38e0ab4977dfc6ee7329cd88367f1162068. ## Entity Status - Public listing published. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd2c8d8b5bf3aaa51a8430f5d636b38e0ab4977dfc6ee7329cd88367f1162068. ## Published Fact - US. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd2c8d8b5bf3aaa51a8430f5d636b38e0ab4977dfc6ee7329cd88367f1162068. ## Committee Appointment - Jill Broadfoot: chair, Audit. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. - Patrick Verheyen: member, Audit. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. - Peter A. Kiener: chair, Compensation. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. - Pamela D. Garzone: member, Compensation. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. - Patrick Verheyen: member, Compensation. Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c. ## Security Listing - CUE (NASDAQ). Claim: alpha:claim:company:3731638e-186d-4843-b67f-ed30d12dca58:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd2c8d8b5bf3aaa51a8430f5d636b38e0ab4977dfc6ee7329cd88367f1162068. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:bd2c8d8b5bf3aaa51a8430f5d636b38e0ab4977dfc6ee7329cd88367f1162068: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/cue-biopharma-inc). - alpha:projection-evidence:document:d64db75ac2a2d3f99c842f92c3566dcdb2b908cbff05c422a4d1c4e4fcd849d3: [Cue Biopharma, Inc. DEF 14A 2026-03-16](https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm). - alpha:projection-evidence:document:f2bdf35e890076f9f2a3f2f6f84355052fb69c6f42337463f00d1ad0dbd2de18: [CUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm). - alpha:projection-evidence:document:eaf99dd1aa5589b67b845e81ab128e8659000f4a69491c7b0b9e3102a9c9232e: [CUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm). - alpha:projection-evidence:document:b6e883872219ad0914e20ee2f9be70862e3d2d522fddd466b231674b9e54182e: [CUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm). - alpha:projection-evidence:document:7d3f1d080fef62e8530fa46ff892f1aa18bd2ac7212e7d068210b46cb5c50710: [CUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm). - alpha:projection-evidence:2b38a5c2d9f3b121533bc26f842a78462761bc26868ead5c745d9d62d5b6021c: [Audit](https://www.sec.gov/Archives/edgar/data/1645460/000119312526108301/cue-20260316.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/cue-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/cue-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/cue-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/cue-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T09:03:42.370576+00:00; recorded 2026-10-17T09:03:42.370576+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.